Gefitinib (ZD 1839)

gefitinib · AstraZeneca

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Gefitinib (ZD 1839), covering 2012-10-30 to 2013-06-24. Get the full timeline:

Most recent: Clinical Trial Update: ZD 1839 in Treating Patients With Metastatic Kidney Cancer [Phase 2]